Results 281 to 290 of about 293,415 (335)
A chimeric viral platform for directed evolution in mammalian cells. [PDF]
Cole AJ+6 more
europepmc +1 more source
An in‐frame deletion was identified in AcIAA27, compared to the susceptible population, which confer resistance to both 2,4‐D and dicamba. Abstract BACKGROUND Two populations of Arctotheca calendula (capeweed) from near Naracoorte, South Australia, were not controlled by 2,4‐D. These populations were investigated for resistance to 2,4‐D and other auxin
Yuanlin Qi+4 more
wiley +1 more source
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa+4 more
wiley +1 more source
AAV yield, bioactivity, and particle heterogeneity are impacted by genome size and non-coding DNA elements. [PDF]
Blahetek G+4 more
europepmc +1 more source
3D Quantification of Viral Transduction Efficiency in Living Human Retinal Organoids
Optimization of viral vectors and their testing in human tissue is crucial to gene therapy development. Conventional technologies to assess virus transduction either lack spatial or temporal information. Here, spatiotemporal mapping of virus transduction in living retinal tissue is introduced, levering fluorescence imaging and machine learning‐based ...
Teresa S. Rogler+11 more
wiley +1 more source
Delivery of a Muscle-Targeted Adeno-Associated Vector Via <i>Ex Vivo</i> Normothermic Perfusion Is Efficient, Durable, and Safe in a Preclinical Porcine Heart Transplant Model. [PDF]
Dewan KC+19 more
europepmc +1 more source
Harnessing synthetic key receptor modulators, this study presents a breakthrough in Wnt/β‐catenin regulation. The FZD agonist RRP‐pbFn bypasses LRP5/6 to drive organoid expansion and tissue regeneration, while the LRP antagonist RRP‐Dkk1c eradicates tumors. These tools enable precise pathway control, advancing regenerative and cancer therapies.
Quanhui Dai+9 more
wiley +1 more source
Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes. [PDF]
Canepari C+15 more
europepmc +1 more source
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma+6 more
wiley +1 more source